Adverse events30

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 30

Type	Event	Organ system	Group	Affected	At risk	Events
other	Cardiovascular disease	Cardiac disorders	Tocilizumab	0	20	0
other	Cardiovascular disease	Cardiac disorders	Placebo	2	10	2
other	Cystic lesion mamma	Reproductive system and breast disorders	Tocilizumab	1	20	1
other	Cystic lesion mamma	Reproductive system and breast disorders	Placebo	0	10	0
other	Gastrointestinal disease	Gastrointestinal disorders	Tocilizumab	1	20	1
other	Gastrointestinal disease	Gastrointestinal disorders	Placebo	0	10	0
other	Glucocorticoid-related hyperglycaemia and myopathia	Blood and lymphatic system disorders	Tocilizumab	1	20	2
other	Glucocorticoid-related hyperglycaemia and myopathia	Blood and lymphatic system disorders	Placebo	1	10	1
other	Infectious disease	Infections and infestations	Tocilizumab	7	20	9
other	Infectious disease	Infections and infestations	Placebo	1	10	1
other	Musculoskeletal disease	Musculoskeletal and connective tissue disorders	Tocilizumab	4	20	5
other	Musculoskeletal disease	Musculoskeletal and connective tissue disorders	Placebo	3	10	6
other	Osteoporotic fracture	Injury, poisoning and procedural complications	Tocilizumab	1	20	1
other	Osteoporotic fracture	Injury, poisoning and procedural complications	Placebo	1	10	1
other	Skin disease	Skin and subcutaneous tissue disorders	Tocilizumab	0	20	0
other	Skin disease	Skin and subcutaneous tissue disorders	Placebo	2	10	2
serious	Gastrointestinal disease	Gastrointestinal disorders	Tocilizumab	3	20	3
serious	Gastrointestinal disease	Gastrointestinal disorders	Placebo	1	10	1
serious	Cardiovascular disease	Cardiac disorders	Tocilizumab	1	20	1
serious	Cardiovascular disease	Cardiac disorders	Placebo	2	10	3

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01450137/events

API reference For AI assistants

Adverse events30

Sources 3

Read this list from software.